Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.790
-0.030 (-1.65%)
At close: Nov 20, 2024, 4:00 PM
1.808
+0.018 (1.01%)
After-hours: Nov 20, 2024, 6:39 PM EST
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $390.54 million as of November 21, 2024. Its market cap has increased by 107.41% in one year.
Market Cap
390.54M
Enterprise Value
459.72M
1-Year Change
107.41%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $390.54M, a decrease of -19.99%. That is a compound annual growth rate of -2.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 397.10M | 69.99% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonida Senior Living | 408.59M |
| Larimar Therapeutics | 407.09M |
| Prime Medicine | 404.48M |
| Canopy Growth | 404.14M |
| 4D Molecular Therapeutics | 400.79M |
| Revance Therapeutics | 394.43M |
| KalVista Pharmaceuticals | 391.10M |
| enGene Holdings | 383.34M |